<DOC>
	<DOCNO>NCT00235014</DOCNO>
	<brief_summary>The BENEDICT study conduct examine effect ACE inhibitor , calcium channel blockade , combination , placebo , prevention micro- macro-albuminuria Type 2 diabetic patient .</brief_summary>
	<brief_title>A Study Prevention Kidney Disease Diabetic Patients ( BENEDICT )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<mesh_term>Trandolapril</mesh_term>
	<criteria>Type 2 Diabetes Hypertension Albuminuria ( Phase A ) Nondiabetic renal disease Subject hypersensitivity ACE inhibitor , CCB</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>hypertension</keyword>
	<keyword>diabetes</keyword>
	<keyword>trandolapril</keyword>
	<keyword>verapamil</keyword>
	<keyword>albuminuria</keyword>
</DOC>